Abstract
Pharmacokinetics and clinical study of aztreonam (AZT) in neonates and premature infants were conducted with the following results:1. Pharmacokinetics(1) Serum concentrations of AZT at 30 minutes after one-shot intravenous injection of 10 mg/kg and 20 mg/kg to neonates including premature infants were 20.6-26.6g/ml and 38.5-46.4 jug/ml, respectively, and decreased thereafter. A dose response was observed in the serum concentrations with administration of AZT 10 mg/kg and 20 mg/kg.
| Original language | English |
|---|---|
| Pages (from-to) | 543-562 |
| Number of pages | 20 |
| Journal | the japanese journal of antibiotics |
| Volume | 43 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 1990 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
- Pharmacology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Pharmacokinetics and clinical studies on aztreonam in neonates and premature infants (the first report)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver